Healthcare News

Clinical investigators from the trial to share real-world experience treating RDEB patients with CORDStrom and present new data from the MissionEB clinical study Boca Raton, FL, Feb. 19, 2026 ...

The estimated fair market value of the Company’s real estate assets is approx $15 million, exceeding the current market cap of approx $13.5 million.

Grand Rapids, Michigan, U.S.A., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Burcon Chiropractic Announces Clinical Trial for Meniere’s Disease Treatment Burcon Chiropractic, in collaboration with the...

MISSION VIEJO, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Leading humanitarian aid non-profit, Human Appeal, announces that it has to date supported over 862,000 people who have fled the current...

Klothea Bio Announces the Launch of a Phase 1b Clinical Trial of AKL003, an Alpha Klotho mRNA Therapeutic, for the Extension of Human Lifespan

Myriad Genetics announced the publication of the analytical validation of the FirstGene® Multiple Prenatal Screen in Clinical Chemistry.

NESS ZIONA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting...

20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth

Omada for Cholesterol closes a critical gap in cardiovascular care, delivering between-visit support for the many adults whose LDL remains uncontrolled.

SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused...